the clinical ( weight gain and oedema ) and metabolic ( hypertension , hypokalaemia and hypernatraemia ) side-effects were reduced by the active amiloride therapy , but serum carbenoxolone levels were not affected .
C0020621
hypokalaemia
C0002502
amiloride